H. pylori eradication does not reduce paraprotein levels in monoclonal gammopathy of unknown significance (MGUS): a prospective cohort study

[1]  A. Chott,et al.  Pathology and clinical course of MALT lymphoma with plasmacytic differentiation. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  M. Luppi,et al.  Helicobacter pylori infection and chronic immune thrombocytopenic purpura: long-term results of bacterium eradication and association with bacterium virulence profiles. , 2007, Blood.

[3]  S. Pizzolitto,et al.  Russell body gastritis: expanding the spectrum of Helicobacter pylori - related diseases? , 2007, Pathology, research and practice.

[4]  S. Montoto,et al.  Monoclonal gammopathy of undetermined significance. , 2006 .

[5]  T Rokkas,et al.  Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report , 2006, Gut.

[6]  E. Kuipers,et al.  Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications. , 2006, The Lancet. Infectious diseases.

[7]  G. Baretton,et al.  Monoclonal Gammopathy of Undetermined Significance and Russell Body Formation in Helicobacter pylori Gastritis , 2006, Helicobacter.

[8]  G. Pizzolo,et al.  Monoclonal gammopathy of undetermined significance and Helicobacter pylori infection , 2006, Annals of Hematology.

[9]  M. Stolte,et al.  Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  J. J. Tai,et al.  Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. , 2005, Journal of the National Cancer Institute.

[11]  A. Montserrat,et al.  Seven versus Ten Days of Rabeprazole Triple Therapy for Helicobacter pylori Eradication: A Multicenter Randomized Trial , 2005, The American Journal of Gastroenterology.

[12]  H. Papadaki,et al.  High prevalence of Helicobacter pylori infection and monoclonal gammopathy of undetermined significance in patients with chronic idiopathic neutropenia , 2005, Annals of Hematology.

[13]  A. Chott,et al.  Monoclonal Immunoglobulin Production Is a Frequent Event in Patients with Mucosa-Associated Lymphoid Tissue Lymphoma , 2004, Clinical Cancer Research.

[14]  B. McMahon,et al.  The Relationship among Previous Antimicrobial Use, Antimicrobial Resistance, and Treatment Outcomes for Helicobacter pylori Infections , 2003, Annals of Internal Medicine.

[15]  T. Therneau,et al.  Helicobacter pylori infection and monoclonal gammopathy of undetermined significance , 2002, British journal of haematology.

[16]  A. Tursi,et al.  Monoclonal Gammopathy of Undetermined Significance Predisposing to Helicobacter pylori‐Related Gastric Mucosa‐Associated Lymphoid Tissue Lymphoma , 2002, Journal of clinical gastroenterology.

[17]  M. Fujishima,et al.  B-cell monoclonality precedes the development of gastric MALT lymphoma in Helicobacter pylori-associated chronic gastritis. , 1998, The American journal of pathology.

[18]  P. Malfertheiner,et al.  A citric acid solution is an optimal test drink in the 13C-urea breath test for the diagnosis of Helicobacter pylori infection. , 1997, Gut.

[19]  J. Bladé.  Clinical practice. Monoclonal gammopathy of undetermined significance. , 2006, The New England journal of medicine.

[20]  R A Kyle,et al.  "Benign" monoclonal gammopathy--after 20 to 35 years of follow-up. , 1993, Mayo Clinic proceedings.